Ensol Biosciences Inc. (XKON:140610)
13,370
+20 (0.15%)
At close: Apr 9, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 184.79 billion as of April 10, 2026. Its market cap has decreased by -49.50% in one year.
Market Cap
184.79B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
13,370.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 184.79B, an increase of 73.99%. That is a compound annual growth rate of 7.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 184.79B | 5.24% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TiumBio | 299.51B |
| curacle co.,ltd. | 296.76B |
| NIBEC | 290.97B |
| Bio Solution | 268.31B |
| Genome & Company | 232.39B |
| ABION | 199.57B |
| ISU Abxis | 188.55B |
| Prestige Biologics | 179.61B |